UPDATE: Breast Cancer Action is planning a rally on the steps of the Supreme Court during oral arguments on April 15th. Find out more, participate in the rally, and help support the cause at the BCAction website: bcaction.org/2013/03/20/human-genes-belong-to-human-beings-not-corporations/
Breast Cancer Action & the ACLU hosted a discussion on January 30th discussing their upcoming Supreme Court case against Myriad Genetics.
BRCA 1 & BRCA 2, aka the "breast cancer genes," are genes that, with certain mutations, can be used to predict the development of breast and ovarian cancer. Myriad Genetics has a patent on these genes, giving them total control over pretty much everything that has to do with the genes. They have created a monopoly that has numerous negative implications for breast cancer patients: prices for the screening test are inflated and expensive; insurance coverage is limited; patients can't get a second opinion of their test results; and other scientists are not allowed to do further research about the BRCA genes, which is needlessly slowing down the progress being made towards discovering a cure.
Read more about the case and how you can give your support:
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?